RBX1 and urinary bladder cancer: Our current study revealed that knockdown of ROC1 expression induced the same effect as MLN4924; therefore, we hypothesized that the combination of cisplatin with hedgehog inhibition by ROC1 silencing would provide a novel strategy to control bladder cancer in the future.